Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Kura Oncology, Inc. reported in an 8-K filed January 6, 2025 that Mollie Leoni, M.D. was appointed Chief Medical Officer, effective January 2, 2025. Mollie Leoni, M.D. has spoken on 1 investor event across 1 company, most recently for Kura Oncology, Inc. on July 27, 2026.
“On January 2, 2025, the Company appointed (i) Mollie Leoni, M.D. as its Chief Medical Officer and (ii) Francis Burrows, Ph.D. as its Chief Scientific Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
SEC 8-K
2025-01-02–present
Recorded roles and call appearances connecting this person to public companies.
KURA
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
